Chinese medicine in postoperative adjuvant chemotherapy (Capecitabine therapy) for colorectal cancer: Examination of prevention of hand-foot syndrome by the prophylactic administration of Eppikajutsutou (clinical phase II study) - Examination of prevention of hand-foot syndrome in Capecitabine therapy by the prophylactic administration of Eppikajutsutou

Yokohama City University Medical Center0 个研究点目标入组 50 人开始时间: 2011年7月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) severe hypersensitivity 2) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ 3) The infectious disease of briskness 4) severe mental disease 5) continuous systemic steroid therapy 6) pregnant or lactating women 7) severe concomitance disease (Interstitial pneumonia, Lung fibrosis, Intestinal paralysis, Intestinal obstruction, uncontrolled Diabetes, Liver cirrhosis or Chronic hepatitis (B type and C type), etc.) 8) organ transplant patient 9) Neoadjuvant therapy (chemotherapy, radiation therapy, and hormone treatment, etc.) 10) colostomy (temporarily contained) 11) Postoperative complications do not recover. 12) remarkable perspiration tendency 13) cardiac dysfunction or cardiac infarction within six months 14) severe hypertension 15) severe renal dysfunction 16) Dysuria 17) Hyperthyroidism 18) improper as patient of clinical trial

发起方